CNBC 快讯 10月29日 19:12 西药业绩显示其并非只有GLP-1概念：为何我们认为仍有上行空间 West Pharma earnings show it's more than a GLP-1 play. Why we see more upside Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more ups… WST XLV 医疗 FG 100 读报告 →